Metabolism of Designer Drugs. Piperazine Derivatives

Sudebno-Meditsinskaya Ekspertisa - Russian Federation
doi 10.17116/sudmed201558349-55
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Inhibition of Noroviruses by Piperazine Derivatives

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2012English

Designer Drugs: A Synthetic Catastrophe

Journal of Reward Deficiency Syndrome
2015English

Psychiatric Aspects of Designer Drugs and New Psychoactive Substances Consumption

Interactive science
2017English

Chemistry, Pharmacology and Toxicology of New Designer Drugs - A Comprehensive Review

Sohag Medical Journal
2017English

Structural Characterization of Cathinone-Type Designer Drugs by EI Mass Spectrometry

Japanese Journal of Forensic Science and Technology
2014English

Computational Study on Prediction of Bioactivity for Regulation of New Designer Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2013English

The Study of Antiarrhythmic Activity of Some Derivatives of 7-Alkyl-8-Piperazine-3-Methylxanthine

Biological Markers and Guided Therapy
2019English

Synthesis and in Vivo Anti-Inflammatory Evaluation of Piperazine Derivatives Containing 1,4-Benzodioxan Moiety

Acta Chimica Slovenica
Chemistry
2019English

Frontispiece: Bio‐Organometallic Derivatives of Antibacterial Drugs

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy